Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 18/20 | 0.94 |
| ▸ | CA1 | P00915 | 16/20 | 0.94 |
| ▸ | CA12 | O43570 | 15/20 | 0.94 |
| ▸ | CA9 | Q16790 | 15/20 | 0.94 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.94 |
| ▸ | CA6 | P23280 | 5/20 | 0.94 |
| ▸ | CA5A | P35218 | 5/20 | 0.94 |
| ▸ | CA7 | P43166 | 5/20 | 0.94 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.94 |
| ▸ | CA4 | P22748 | 4/20 | 0.94 |
| ▸ | CA3 | P07451 | 4/20 | 0.94 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.94 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.94 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.60 |
| ▸ | HTR6 | P50406 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzenesulfonamide SCHEMBL729 | 0.97 | CA2 (1.00) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL6868390 | 0.97 | CA2 (1.00) | CA2CA1CA12CA9CA14 | |
| SCHEMBL19479299 | 0.97 | CA2 (1.00) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL29825137 | 0.97 | CA2 (1.00) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL1332409 | 0.97 | CA2 (1.00) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL28257999 | 0.97 | CA2 (1.00) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL861258 | 0.94 | CA2 (0.94) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL1009443 | 0.94 | CA2 (0.94) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL11798700 | 0.94 | CA2 (0.94) | CA2CA1CA12CA9CA14 | |
| Benzenesulfonamide SCHEMBL3100364 | 0.94 | CA2 (0.94) | CA2CA1CA12CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0919546-B1 | Process for 4-sulfonamidophenyl hydrazines | AEROJET FINE CHEMICALS LLC (US) | 2002-01-23 | — | — | EP | claimed |
| US-6011177-A | Process for 4-sulfonamidolphenyl hydrazines | AEROJET-GENERAL CORPORATION (US) | 2000-01-04 | — | — | US | claimed |
| EP-0919546-A1 | Process for 4-sulfonamidophenyl hydrazines | AEROJET-GENERAL CORPORATION (US) | 1999-06-02 | — | — | EP | claimed |
| CN-112986410-B | Method for detecting arylamine and aromatic hydrazine gene toxic impurities in celecoxib | 南京亿华药业有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-112986410-A | Method for detecting arylamine and aromatic hydrazine gene toxic impurities in celecoxib | 南京亿华药业有限公司 | 2021-06-18 | — | — | CN | disclosed |
| CN-208437420-U | A kind of Petroleum concentration soil treatment system | 毅康科技有限公司 | 2019-01-29 | — | — | CN | disclosed |
| CN-108273839-A | A kind of Petroleum concentration soil treatment system | 毅康科技有限公司 | 2018-07-13 | — | — | CN | disclosed |
| CN-103665636-B | A kind of igelite building template | JIANGYIN KUANGSHI BUILDING MATERIALS CO., LTD. (CN) | 2015-12-30 | — | — | CN | disclosed |
| CN-103665636-A | PVC (polyvinyl chloride) plastic building template | JIANGYIN KUANGSHI BUILDING MATERIALS CO LTD | 2014-03-26 | — | — | CN | disclosed |
| EP-0919546-B1 | Process for 4-sulfonamidophenyl hydrazines | AEROJET FINE CHEMICALS LLC (US) | 2002-01-23 | — | — | EP | disclosed |
| US-6011177-A | Process for 4-sulfonamidolphenyl hydrazines | AEROJET-GENERAL CORPORATION (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0919546-A1 | Process for 4-sulfonamidophenyl hydrazines | AEROJET-GENERAL CORPORATION (US) | 1999-06-02 | — | — | EP | disclosed |